Clinical Trial Update: 6MW3511 in Patients With Advanced Solid Tumor [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for 6MW3511 in advanced solid tumors across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• 6MW3511

Snippet

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. | Conditions: Solid Tumors | Phase 1, Phase 2 | Status: UNKNOWN